91 related articles for article (PubMed ID: 32172603)
1. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
[TBL] [Abstract][Full Text] [Related]
2. Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population.
Alonso GT; Triolo TM; Akturk HK; Pauley ME; Sobczak M; Forlenza GP; Sakamoto C; Pyle L; Frohnert BI
Diabetes Care; 2023 Jun; 46(6):1218-1222. PubMed ID: 37023293
[TBL] [Abstract][Full Text] [Related]
3. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria.
Galindo RJ; Aleppo G; Parkin CG; Baidal DA; Carlson AL; Cengiz E; Forlenza GP; Kruger DF; Levy C; McGill JB; Umpierrez GE
J Diabetes Sci Technol; 2024 Jul; 18(4):974-987. PubMed ID: 36524477
[TBL] [Abstract][Full Text] [Related]
4. Impact of Expanding Access to Continuous Glucose Monitoring Systems Among Insulin Users with Type 1 or Type 2 Diabetes.
Pathak S; Kearin K; Kahkoska AR; Fuller KA; Staats B; Albright J; Stürmer T; Buse JB; Urick BY
Diabetes Technol Ther; 2023 Mar; 25(3):169-177. PubMed ID: 36480256
[No Abstract] [Full Text] [Related]
5. Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes.
Ahn D; Pettus J; Edelman S
J Diabetes Sci Technol; 2016 May; 10(3):793-8. PubMed ID: 26884422
[TBL] [Abstract][Full Text] [Related]
6. Disparities in Continuous Glucose Monitor Use Between Children With Type 1 Diabetes Living in Urban and Rural Areas.
Tilden DR; French B; Datye KA; Jaser SS
Diabetes Care; 2024 Mar; 47(3):346-352. PubMed ID: 37906202
[TBL] [Abstract][Full Text] [Related]
7. Development of a Continuous Glucose Monitoring Service by Clinical Pharmacists in a Medically Underserved Population.
Lingow S; Kinnikin K; Guyton J
Innov Pharm; 2024; 15(1):. PubMed ID: 38779106
[No Abstract] [Full Text] [Related]
8. Evaluation of a Pharmacist-Led Personal Continuous Glucose Monitor Workflow to Improve Glycemic Management in an Internal Medicine Clinic.
Pasour T; Sheehan L; Troyer M; Conger M; Carson P
J Am Pharm Assoc (2003); 2024 May; ():102139. PubMed ID: 38823557
[TBL] [Abstract][Full Text] [Related]
9. Recruitment Into a Pediatric Continuous Glucose Monitoring RCT.
Volkening LK; Gaffney KC; Katz ML; Laffel LM
J Diabetes Sci Technol; 2017 Jan; 11(1):100-107. PubMed ID: 27340247
[TBL] [Abstract][Full Text] [Related]
10. Inequalities in Access to Diabetes Technologies in Children with Type 1 Diabetes: A Multicenter, Cross-sectional Study from Türkiye.
Karakus KE; Sakarya S; Yıldırım R; Özalkak Ş; Özbek MN; Yıldırım N; Delibağ G; Eklioğlu BS; Haliloğlu B; Aydın M; Kırmızıbekmez H; Gökçe T; Can E; Eviz E; Yeşiltepe-Mutlu G; Hatun Ş
J Clin Res Pediatr Endocrinol; 2024 Jul; ():. PubMed ID: 38953734
[TBL] [Abstract][Full Text] [Related]
11. Health Literacy of Patients using Continuous Glucose Monitoring.
Evans EI; Pincus KJ; Seung H; Rochester-Eyeguokan CD
J Am Pharm Assoc (2003); 2024 Apr; ():102109. PubMed ID: 38663532
[TBL] [Abstract][Full Text] [Related]
12. Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review.
Oganesova Z; Pemberton J; Brown A
Diabet Med; 2024 Jun; ():e15369. PubMed ID: 38925143
[TBL] [Abstract][Full Text] [Related]
13. Skin Reactions in Children with Type 1 Diabetes Associated with the Use of New Diabetes Technologies-An Observational Study from a Regional Polish Pediatric Diabetes Center.
Ledwoń E; Zemła-Szten P; von dem Berge T; Nalewajko K; Passanisi S; Piona C; Dos Santos TJ; Svensson J; Korsgaard Berg A; Chobot A;
Children (Basel); 2024 Jun; 11(6):. PubMed ID: 38929319
[TBL] [Abstract][Full Text] [Related]
14. The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review.
Been RA; Lameijer A; Gans ROB; van Beek AP; Kingsnorth AP; Choudhary P; van Dijk PR
Ther Adv Endocrinol Metab; 2024; 15():20420188241236289. PubMed ID: 38476216
[TBL] [Abstract][Full Text] [Related]
15. Demographic Variables Associated With Diabetes Technology Awareness or Use in Adults With Type 2 Diabetes.
Ye Y; Acevedo Mendez BA; Izard S; Myers AK
Diabetes Spectr; 2024; 37(1):60-64. PubMed ID: 38385093
[TBL] [Abstract][Full Text] [Related]
16. Increasing Continuous Glucose Monitoring Use for Non-Hispanic Black and Hispanic People With Type 1 Diabetes: Results From the T1D Exchange Quality Improvement Collaborative Equity Study.
Odugbesan O; Mungmode A; Rioles N; Buckingham D; Nelson G; Agarwal S; Grant A; Wright T; Hess E; Ebekozien O;
Clin Diabetes; 2024; 42(1):40-48. PubMed ID: 38230339
[TBL] [Abstract][Full Text] [Related]
17. Zooming In, Then Out: Why We Must Apply Human-Centered Design to Transform Diabetes Technology.
Chao EC
J Diabetes Sci Technol; 2024 Jan; 18(1):193-195. PubMed ID: 37970832
[TBL] [Abstract][Full Text] [Related]
18. Type 1 Diabetes Continuous Glucose Monitoring Use in the Pediatric Emergency Department Affects Laboratory Test Frequency but Not Treatment Timing.
Baker RK; Filipp SL; Jacobsen LM
Diabetes Spectr; 2023; 36(3):275-280. PubMed ID: 37583555
[TBL] [Abstract][Full Text] [Related]
19. Use of continuous glucose monitoring in obesity research: A scoping review.
Hegedus E; Salvy SJ; Wee CP; Naguib M; Raymond JK; Fox DS; Vidmar AP
Obes Res Clin Pract; 2021; 15(5):431-438. PubMed ID: 34481746
[TBL] [Abstract][Full Text] [Related]
20. Continuous Glucose Monitoring Use in Clinical Trials for On-Market Diabetes Drugs.
Fox BQ; Benjamin PF; Aqeel A; Fitts E; Flynn S; Levine B; Maslak E; Milner RL; Ose B; Poeschla M; Ray M; Serino M; Shah SS; Close KL
Clin Diabetes; 2021 Apr; 39(2):160-166. PubMed ID: 33986569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
